Proton Therapy & Advanced Radiotherapeutics

Embark on a journey of innovation and discovery as we explore the latest advancements and emerging technologies reshaping the landscape of pediatric radiation oncology, offering new possibilities for cancer control, survivorship, and quality of life.

• Advanced Radiation Delivery Systems: Investigates novel radiation delivery platforms such as stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), and magnetic resonance-guided radiation therapy (MRgRT), offering enhanced tumor targeting, adaptive treatment planning, and real-time imaging capabilities to improve treatment precision, tumor control rates, and normal tissue sparing for children undergoing radiation therapy for complex or recurrent cancers.
• Radiomics and Artificial Intelligence: Explores the integration of radiomics and artificial intelligence (AI) algorithms into pediatric radiation oncology workflows to extract quantitative imaging features, predict treatment outcomes, and personalize treatment plans based on tumor biology, radiographic characteristics, and patient-specific factors, offering insights into pediatric tumor heterogeneity, treatment response, and treatment resistance for optimized cancer care and precision medicine applications.
• Biomarker-Guided Radiation Therapy: Investigates the use of biomarkers, genomic signatures, and molecular profiling techniques to identify radiation-sensitive pediatric tumors, predict treatment response, and stratify children for personalized radiation therapy approaches, offering opportunities for targeted dose escalation, treatment intensification, or treatment deintensification based on individual tumor biology, treatment responsiveness, and clinical outcomes, optimizing therapeutic efficacy and minimizing treatment-related toxicity for children with cancer across diverse disease sites and treatment scenarios.
• Pediatric Radiation Oncology Clinical Trials: Explores novel treatment strategies, combination therapies, and therapeutic innovations through participation in pediatric radiation oncology clinical trials, offering children and their families access to investigational treatments, cutting-edge technologies, and promising therapeutic approaches beyond standard of care options, contributing to advancements in childhood cancer research, treatment optimization, and quality improvement initiatives to transform the future of pediatric cancer care and improve patient outcomes globally.